Owens & Minor is focused on paying down debt and rethinking how it builds momentum in its “pure-play” Patient Direct business ...

On Monday, Owens & Minor Inc. (NYSE:OMI) reported adjusted earnings for the second quarter that missed analyst projections as ...

Owens & Minor's canceled Rotech deal eases financial risks. Click to read a full investment analysis of OMI stock and why its ...

Owens & Minor says it is in the final stages of selling its Products & Healthcare Services segment, says CEO Ed Pesicka.

Citigroup analyst Daniel Grosslight maintained Owens & Minor with a Buy and lowered the price target from $11 to $7. Baird ...

Owens & Minor Inc (OMI) reports a 3.3% revenue increase while focusing on strategic divestitures and overcoming supply chain ...

Medical supply and logistics company Owens & Minor (NYSE:OMI) will be announcing earnings results this Monday before market ...

Owens & Minor Inc (NYSE:OMI) is set to release its Q2 2025 earnings on Aug 11, 2025. The consensus estimate for Q2 2025 ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...